Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Perry

Showing results (201-210 of 206) with videos related to

Pageof 21
Sort By:
You have reached the last page of results.This site can display upto 206 results.
Schizophrenia Bulletin|October 27, 2025
Testing the Transportability of the Psychosis Metabolic Risk Calculator in Canada (Quebec): International External Validation StudySébastien Brodeur, Olivier Corbeil, Laurent Béchard, et al.
Schizophrenia Bulletin|December 10, 2024
Metformin for the Prevention of Antipsychotic-Induced Weight Gain: Guideline Development and Consensus ValidationAoife Carolan, Caroline Hynes-Ryan, Sri Mahavir Agarwal, et al.
The Lancet. Psychiatry|March 14, 2026
Cardiometabolic prediction models for young people with psychosis spectrum disorders in the UK (PsyMetRiC 2.0): a retrospective, multicohort clinical prediction model studyBenjamin I Perry, Emanuele F Osimo, Shuqing Si, et al.
The Lancet Regional Health. Europe|August 30, 2022
The psychosis metabolic risk calculator (PsyMetRiC) for young people with psychosis: International external validation and site-specific recalibration in two independent European samplesBenjamin I Perry, Frederik Vandenberghe, Nathalia Garrido-Torres, et al.
The Lancet. Psychiatry|August 14, 2025
Holistic prevention and management of physical health side-effects of psychotropic medication: second report of the Lancet Psychiatry Physical Health CommissionSean Halstead, Chloe X Yap, Nicola Warren, et al.
BMC Biology|February 6, 2025
Same data, different analysts: variation in effect sizes due to analytical decisions in ecology and evolutionary biologyElliot Gould, Hannah S Fraser, Timothy H Parker, et al.
Pageof 21

Showing results (201-210 of 206) with videos related to

Sort By:
Pageof 21
You have reached the last page of results.This site can display upto 206 results.
Schizophrenia Bulletin|October 27, 2025
Testing the Transportability of the Psychosis Metabolic Risk Calculator in Canada (Quebec): International External Validation StudySébastien Brodeur, Olivier Corbeil, Laurent Béchard, et al.
Schizophrenia Bulletin|December 10, 2024
Metformin for the Prevention of Antipsychotic-Induced Weight Gain: Guideline Development and Consensus ValidationAoife Carolan, Caroline Hynes-Ryan, Sri Mahavir Agarwal, et al.
The Lancet. Psychiatry|March 14, 2026
Cardiometabolic prediction models for young people with psychosis spectrum disorders in the UK (PsyMetRiC 2.0): a retrospective, multicohort clinical prediction model studyBenjamin I Perry, Emanuele F Osimo, Shuqing Si, et al.
The Lancet Regional Health. Europe|August 30, 2022
The psychosis metabolic risk calculator (PsyMetRiC) for young people with psychosis: International external validation and site-specific recalibration in two independent European samplesBenjamin I Perry, Frederik Vandenberghe, Nathalia Garrido-Torres, et al.
The Lancet. Psychiatry|August 14, 2025
Holistic prevention and management of physical health side-effects of psychotropic medication: second report of the Lancet Psychiatry Physical Health CommissionSean Halstead, Chloe X Yap, Nicola Warren, et al.
BMC Biology|February 6, 2025
Same data, different analysts: variation in effect sizes due to analytical decisions in ecology and evolutionary biologyElliot Gould, Hannah S Fraser, Timothy H Parker, et al.
Pageof 21